Comunicati.net - Comunicati pubblicati - Market Data Forecast Comunicati.net - Comunicati pubblicati - Market Data Forecast Sat, 20 Jan 2018 00:31:30 +0100 Zend_Feed_Writer 1.11.10 (http://framework.zend.com) http://comunicati.net/utenti/23202/1 Europe Medical Nonwovens Market Thu, 11 Jan 2018 17:42:06 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465598.html http://comunicati.net/comunicati/aziende/tecnologia/465598.html Market Data Forecast Market Data Forecast In this region, The Europe Medical Nonwovens Market is projected to reach USD 2,756.6 million by 2024, from USD 2,046.7 million in 2016 growing at a CAGR of 3.8% in the forecast period 2017 to 2024.

 

Based on geography, the Europe medical nonwovens market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-medical-nonwovens-market-analysis-industry-outlook-and-forecast-2017-to-2024/1359910841

 

Europe medical nonwovens market competition by top players including -

Berry Plastics Group, Inc. is going to dominate the medical nonwovens market followed with Halyard Health, Inc., and Fraudenberg Performance Material, along with others such as

Avgol Ltd.,

Fibertex Non Wovens A/S and Pegas Nonwovens,

3M,

KCWW,

Halyard Health, Inc.,

Advanced Fabrics (SAAF),

Biovation LLC,

Intco Medical,

Ahlstrom Corporation,

Ansell Healthcare,

Asahi Kasei Corporation,

Cypress Medical Products,

Dynarex Corporation,

Georgia-Pacific,

Hogy Medical,

Molnlycke Health Care AB,

Paul Hartmann AG,

Precision Fabrics Group, Inc.,

Domtar Corporation,

Cardinal Health,

UniCharm Corporation,

Kraton Performance Polymers Inc.,

Medline Industries, Inc.

 

Request free sample @ https://www.researchcosmos.com/request/1359910841

 

The Europe medical nonwovens market is segmented on the basis of type, product type, usability, end user, distribution channel and geography.

 

On the basis of type, medical nonwovens are categorized into spunbond, meltblown, drylaid, wetlaid and spun-melt-spun (SMS).

 

On the basis of product type, the medical nonwovens market is segmented into hygiene and apparel products.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1359910841

 

On the basis of product type, hygiene is sub-segmented into incontinence pads, ostomy liners, disposable underwear’s, CSR wraps, disposable medical wipes and diapers.

 

Apparel products are sub-segmented into surgical masks, surgical packs, surgical drapes and gowns, surgical caps and wound care material.

 

On the basis of end-user, this market is segmented into hospitals, clinics, home healthcare, laboratories and ambulatory surgical centers.

 

Check for discount @https://www.researchcosmos.com/discount/1359910841

 

On the basis of distribution channel, the Europe medical nonwovens market is segmented into direct tenders and retail

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

 

www.researchcosmos.com

]]>
Europe IUCD Devices Market Thu, 11 Jan 2018 17:41:48 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465597.html http://comunicati.net/comunicati/aziende/tecnologia/465597.html Market Data Forecast Market Data Forecast In this region, Europe IUCD Devices Market is projected to reach USD 757.5 million by 2024, from USD 561.7 million in 2016 growing at a CAGR of 3.9% in the forecast period 2017 to 2024

 

Based on geography, the Europe IUCD devices market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-intra-uterine-contraceptive-devices-market-analysis-industry-outlook-and-forecast-2017-to-2/1457411170

 

Europe IUCD devices market competition by top players including –

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include

DKT International,

Egemen International,

Melbea AG,

Ocon Medical Ltd.,

Pregna International Limited,

Medical Engineering Corporation SA ,

SMB Corporation and Meril Life Sciences Pvt. Ltd.,

Medu Scientific Ltd, China RH Contraceptives Co., Ltd,

Sanghai Jolly Medical Education Co., Ltd,

Bernstein Leibhard LLP,

Zheijang Daji Medical Instruments, Ltd.,

Nimble International,

AME Line, Technico,

Cepeo,

Contraceptivos,

Injeflex Ind and Com Ltda,

Bersil,

Amed.

 

Request free sample @ https://www.researchcosmos.com/request/1457411170

 

The Europe intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

 

The Europe intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1457411170

 

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

 

Check for discount @https://www.researchcosmos.com/discount/1457411170

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

 

]]>
Europe Hemostats Market Thu, 11 Jan 2018 17:41:30 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465596.html http://comunicati.net/comunicati/aziende/tecnologia/465596.html Market Data Forecast Market Data Forecast In this region, Europe Hemostats Market is projected to reach USD 1,093.7 million by 2024, from USD 641.6 million in 2016 growing at a CAGR of 6.9% in the forecast period 2017 to 2024.

 

Based on geography, the Europe hemostats market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-hemostats-market-analysis-industry-outlook-and-forecast-2017-to-2024/791251161

 

Europe hemostats market competition by top players including -

Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as

Baxter,

Vascular Solutions, Inc.,

B.BraunMelsungen,

3-D Matrix, Ltd.,

Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company),

Anika Therapeutics, Inc.,

Arch Therapeutics Inc.,

Biom’Up SAS,

CryoLife, Inc.,

Gamma Therapeutics, Inc.,

Hemostasis, LLC,

MedTrade Products Limited, I

ntegraLifeSciences Corporation,

Medline Industries, Inc.,

HEMOTEC MEDICAL GMBH,

Stryker,

CSL Behring,

Mallinckrodt,

Equimedical, B.V.

Request free sample @ https://www.researchcosmos.com/request/791251161

 

The Europe hemostats market is segmented on the basis of type, application, distribution channel, and end user.

 

The Europe hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/791251161

 

On the basis of application, the market is segmented into surgery and wound closure.

 

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics.

 

Check for discount @https://www.researchcosmos.com/discount/791251161

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
Europe Advanced Wound Care Market Thu, 11 Jan 2018 17:41:03 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465595.html http://comunicati.net/comunicati/aziende/tecnologia/465595.html Market Data Forecast Market Data Forecast In this region, The Europe Advanced Wound Care Market is expected to reach USD 5,144.5 million by 2024, from USD 3,224.6 million in 2016 growing at a CAGR of 6.1% in the forecast period 2017 to 2024.

 

Based on geography, the Europe advanced wound care market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland and

Rest of Europe.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/europe-advanced-wound-care-market-analysis-industry-outlook-and-forecast-2017-to-2024/379743644

 

Europe advanced wound care market competition by top players including -

Smith and Nephew Plc.

Acelity L.P., Inc.

Mölnlycke Health Care

Coloplast Corp.

ConvaTec, Inc.

3M Health care

Medtronic

Integra Lifesciences Corporation

 

Request free sample @ https://www.researchcosmos.com/request/379743644

 

The Europe advanced wound care market is segmented into three product types, namely, dressing, biologics, and therapy devices.

 

Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing.

 

Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/379743644

 

Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF)

 

Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies

 

Based on NPWT type, the market is segmented into stand-alone NPWT devices, portable NPWT devices and disposable NPWT devices.

 

Based on PRD type, the market is segmented into mattress and bed.

 

Check for discount @https://www.researchcosmos.com/discount/379743644

 

Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.

 

Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.

 

Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.

 

Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, and venous ulcer among others.

 

On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.

 

On the basis of end user the market is segmented into direct tenders, and retails.

 

On the basis of distribution channel the market is segmented into direct tenders, and retails.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
Asia-Pacific Surgical Staplers Market Thu, 11 Jan 2018 17:40:41 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465594.html http://comunicati.net/comunicati/aziende/tecnologia/465594.html Market Data Forecast Market Data Forecast In this report, The Asia-Pacific Surgical Staplers Market is projected to reach USD 682.4 million by 2024, from USD 336.8 million in 2016 growing at a CAGR of 9.3% in the forecast period 2017 to 2024. 


Based on geography, the APAC surgical staplers market is segmented into 11 geographical regions, such as, 
Japan, 
China, 
South Korea, 
India, 
Australia, 
Singapore, 
Thailand, 
Malaysia, 
Indonesia, 
Philippines and 
Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-surgical-staplers-market-analysis-industry-outlook-and-forecast-2017-to-2024/603064187


APAC surgical staplers market competition by top players including -
Covidien (MEDTRONIC), 
Ethicon, Cardica Inc., 
Smith and Nephew Plc, 
CONMED Corporation, 
Purple Surgical Inc., 
Welfare Medical Ltd, 
Reach Surgical., 
Grena Ltd., 
B.BraunMelsungen AG, 
Frankenman International Limited, 
Zimmer Biomet, 
Stryker, 
Meril Life Sciences Pvt. Ltd., 
Touchstone International Medical Science Co. Ltd. 


The APAC surgical staplers market is segmented on the basis of product type, type, application, end-user, distribution channel, and geography. 

 

Request free sample @ https://www.researchcosmos.com/request/603064187


On the basis of product types, the APAC surgical staplers market is segmented into two product type which includes manual and powered surgical staplers. 


On the basis of type, the APAC surgical staplers market is segmented into disposable and reusable surgical staplers. 

 

Inquire before buying @ https://www.researchcosmos.com/inquire/603064187


On the basis of application, the APAC surgical staplers market is segmented into abdominal surgery, general surgery, cardiac surgery, thoracic surgery, hemorrhoids surgery, and others. 


On the basis of end users, the market is classified into hospitals, clinics, and ambulatory surgical centers.
On the basis of distribution channel, the APAC surgical staplers market is segmented into direct tenders and retail. 

 

Check for discount @https://www.researchcosmos.com/discount/603064187

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
APAC Topical Drug Delivery Market Thu, 11 Jan 2018 17:40:22 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465593.html http://comunicati.net/comunicati/aziende/tecnologia/465593.html Market Data Forecast Market Data Forecast In this report, APAC Topical Drug Delivery Market is expected to reach USD 34.1 billion by 2024, from USD 11.28 billion in 2016 growing at a CAGR of 14.9% in the forecast period 2017 to 2024.

 

Based on geography, the APAC topical drug delivery market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-topical-drug-delivery-market-analysis-industry-outlook-and-forecast-2017-to-2024/126209639

 

APAC topical drug delivery market competition by top players including -

Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the APAC topical drug delivery market are

MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company),

Crescita Therapeutics,

West Pharmaceutical Services,

Biofarmitalia s.r.l,

Pharmatek Laboratories, Inc.,

Stiefel Laboratories, Inc.,

Tapemark, Acrux Limited,

Nitto Denko Corporation,

Skinvisible Pharmaceuticals, Inc.,

Mylan Pharmaceuticals Inc.,

Pocono Coated Products LLC,

TheraSolve NV.,

Samyang Biopharmaceuticals Corporation,

Lohmann Therapie-Systeme AG,

Prosollus Pharmaceuticals,

Easton Pharmaceuticals Inc.,

Novosis AG,

Endo Pharmaceuticals Inc.,

Transdermal Technologies, Inc.,

Sheffield Pharmaceuticals, Inc.,

Solvay

 

Request free sample @ https://www.researchcosmos.com/request/126209639

 

The APAC topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.

 

On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/126209639

 

Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.

 

The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.

 

The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.

 

Check for discount @https://www.researchcosmos.com/discount/126209639

 

On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

 

www.researchcosmos.com

]]>
APAC Sleep Apnea Devices Market Thu, 11 Jan 2018 17:40:00 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465592.html http://comunicati.net/comunicati/aziende/tecnologia/465592.html Market Data Forecast Market Data Forecast In this region, The APAC Sleep Apnea Devices Market is expected to reach USD 2,146.8 million by 2024, from USD 996.5million in 2016 growing at a CAGR of 10.1% in the forecast period of 2017 to 2024.

 

Based on geography, the APAC sleep apnea devices market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-sleep-apnea-device-market-analysis-industry-outlook-and-forecast-2017-to-2024/1658589268

 

APAC sleep apnea devices market competition by top players including –

Koninklijke Philips N.V. dominated the sleep apnea devices market in 2016, followed by Natus Medical Incorporated, and Nihon Kohden along with others such as

CareFusion Corporation,

Curative Medical Inc.,

ResMed,

Fisher and Paykel Healthcare Limited.,

SomnoMed,

BMC Medical Co., Ltd.,

Compumedics Limited,

NatusMedical Inc.,

DeVilbiss Healthcare,

Global Medical Holdings,

Itamar Medical Ltd.,

Weinmann Medical Technology,

Cleveland Medical Devices Inc.,

SOMNOmedics GmbH,

Deymed Diagnostic,

NovaSom,

Medtronic.

 

Request free sample @ https://www.researchcosmos.com/request/1658589268

 

The APAC sleep apnea device market is segmented on the basis of product type, end user and geography.

 

On the basis of type, sleep apnea device market is categorized into: diagnostic devices and therapeutic devices.

 

On the basis of product type, the diagnostic sleep apnea device market is segmented into polysomnography devices, respiratory polygraphs, pulse oximeters and actigraph systems.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1658589268

 

On the basis of product type, the therapeutic sleep apnea devices are segmented into positive airway pressure devices (PAP), continuous positive airway pressure devices (CPAP), automatically adjusting positive airway pressure devices (APAP), masks, adaptive servo ventilation, airway clearance system, oxygen concentrators, oral appliances and accessories.

 

On the basis of end users, the APAC sleep apnea devices market is further segmented into hospitals, sleep clinics, community healthcare and home healthcare. In 2017, the hospitals segment dominates the global sleep apnea device market.

 

Check for discount @https://www.researchcosmos.com/discount/1658589268

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
APAC Radiotherapy Market Thu, 11 Jan 2018 17:39:40 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465590.html http://comunicati.net/comunicati/aziende/tecnologia/465590.html Market Data Forecast Market Data Forecast In this region, The APAC Radiotherapy Market is projected to reach USD 2,342.3 million by 2024, from USD 989.5 million in 2016 growing at a CAGR of 11.5% in the forecast period 2017 to 2024.

 

Based on geography, the APAC radiotherapy market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-radiotherapy-market-analysis-industry-outlook-and-forecast-2017-to-2024/191444246

 

APAC radiotherapy market competition by top players including –

Varian Medical Systems, Inc. dominated the radiotherapy market followed by Elekta AB, and Accuray, Inc. along with others

CIVCO Medical Solutions,

Brainlab AG,

C. R. Bard, Inc.,

IsoRay Medical, Inc.,

Nordion, Inc.,

RaySearch Laboratories AB,

PRECISIS AG,

Mevion Medical Systems, Inc.,

TechnicasRadiofiscas S.L.,

Hitachi, Ltd.,

Sumitomo Heavy Industries, Ltd.,

Mitsubishi Electric Corporation,

ProNova Solutions, LLC,

ProTom International

 

Request free sample @ https://www.researchcosmos.com/request/191444246

 

The APAC radiotherapy market is segmented on the basis of type, product type, indication, and geography.

 

The APAC radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy.

 

Radiotherapy market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/191444246

 

The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology.

 

The brachytherapy is segmented into LDR and HDR.

 

On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy softwares and systematic radiotherapy.

 

External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife.

 

Check for discount @https://www.researchcosmos.com/discount/191444246

 

The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders.

 

The radiotherapy softwares is segmented into treatment planning softwares, dosage planning softwares, patient positioning softwares and image guiding softwares.

 

On the basis of indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

 

www.researchcosmos.com

]]>
APAC Molecular Spectroscopy Market Thu, 11 Jan 2018 17:39:21 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465589.html http://comunicati.net/comunicati/aziende/tecnologia/465589.html Market Data Forecast Market Data Forecast In this region, APAC Molecular Spectroscopy Market is projected to reach USD 1,515.6 million by 2024, from USD 783.4 million in 2016 growing at a CAGR of 8.6% in the forecast period 2017 to 2024.

 

Based on geography, the APAC molecular spectroscopy market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-molecular-spectroscopy-market-analysis-industry-outlook-and-forecast-2017-to-2024/1138283432

 

APAC molecular spectroscopy market competition by top players including –

Bruker is going to dominate the molecular spectroscopy market followed by Thermofisher Scientific, Inc. and, Agilent Technologies along with others such as

ABB,

Avantes,

Block Engineering,

Carl Zeiss Spectroscopy GmbH,

Cobalt Light Systems Ltd,

Galaxy Scientific,

Gasera,

Ibsen Photonics,

Industrial Test Systems, Inc.,

Kaiser Optical Systems, Inc.,

Keit Spectrometers,

Magritek,

EMD Millipore Corporation,

PerkinElmer Inc.,

Raptor Photonics PLC,

Shimadzu Corporation,

Spectral Evolution,

Viavi Solutions,

WITec GmbH,

B&W Tek, StellarNet,

Si-WareSystems,

Foss,

Jasco, Inc.,

Jeol Ltd.

 

Request free sample @ https://www.researchcosmos.com/request/1138283432

 

The APAC molecular spectroscopy market is segmented on the basis of technology, type, application, and geography.

 

Based on technology, the APAC molecular spectroscopy market is segmented into nuclear magnetic resonance (NMR) spectroscopy, UV visible spectroscopy, infrared (IR) spectroscopy, near infrared spectroscopy (NIR), Raman spectroscopy and others.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1138283432

 

The NMR spectroscopy is further segmented into fourier transform (FT-NMR), continuous wave, and solid state spectroscopy. UV visible spectroscopy is further segmented into single beam, double beam, array based and handheld spectroscopy.

 

IR spectroscopy is segmented based on spectrum into mid wave, short wave and far wave IR spectroscopy. Far wave IR spectroscopy segment is expected to grow at the highest CAGR in the forecast period2017-2024.

 

Based on product types, the IR spectroscopy market is segmented into bench top, infrared microscopy, portable, hyphenated and terahertz IR spectroscopy. Terahertz IR spectroscopy is the highest growing market segment.

 

Check for discount @https://www.researchcosmos.com/discount/1138283432

 

The NIR spectroscopy is again further categorized into scanning, Fourier transform, portable/handheld and filter NIR spectroscopy. Based on product type, Raman spectroscopy is further segmented into micro Raman, probe based and FT Raman.

 

On the basis of application, the APAC molecular spectroscopy market is classified into pharmaceutical, food and beverages, environmental testing, biotechnology, academics and research and, others.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
APAC Medical Nonwovens Market Thu, 11 Jan 2018 17:38:57 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465588.html http://comunicati.net/comunicati/aziende/tecnologia/465588.html Market Data Forecast Market Data Forecast In this region, The APAC Medical Nonwovens Market is projected to reach USD 2454.2 million by 2024, from USD 1097.9 in 2016 growing at a CAGR of 13% in the forecast period 2017 to 2024.

 

Based on geography, the APAC medical nonwovens market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-medical-nonwovens-market-analysis-industry-outlook-and-forecast-2017-to-2024/52004484

 

APAC medical nonwovens market competition by top players including –

Berry Plastics Group, Inc. is going to dominate the medical nonwovens market followed with Halyard Health, Inc., and Fraudenberg Performance Material, along with others such as

Avgol Ltd.,

Fibertex Non Wovens A/S and Pegas Nonwovens,

3M,

KCWW,

Halyard Health, Inc.,

Advanced Fabrics (SAAF),

Biovation LLC,

Intco Medical,

Ahlstrom Corporation,

Ansell Healthcare,

Asahi Kasei Corporation,

Cypress Medical Products,

Dynarex Corporation,

Georgia-Pacific,

Hogy Medical,

Molnlycke Health Care AB,

Paul Hartmann AG,

Precision Fabrics Group, Inc.,

Domtar Corporation,

Cardinal Health,

UniCharm Corporation,

Kraton Performance Polymers Inc.,

Medline Industries, Inc.

 

Request free sample @ https://www.researchcosmos.com/request/52004484

 

The APAC medical nonwovens market is segmented on the basis of type, product type, usability, end user, distribution channel and geography.

 

On the basis of type, medical nonwovens are categorized into spunbond, meltblown, drylaid, wetlaid and spun-melt-spun (SMS).

 

On the basis of product type, the medical nonwovens market is segmented into hygiene and apparel products.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/52004484

 

On the basis of product type, hygiene is sub-segmented into incontinence pads, ostomy liners, disposable underwear’s, CSR wraps, disposable medical wipes and diapers.

 

Apparel products are sub-segmented into surgical masks, surgical packs, surgical drapes and gowns, surgical caps and wound care material.

 

On the basis of end-user, this market is segmented into hospitals, clinics, home healthcare, laboratories and ambulatory surgical centers.

 

Check for discount @https://www.researchcosmos.com/discount/52004484

 

On the basis of distribution channel, the global medical nonwovens market is segmented into direct tenders and retail

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

 

www.researchcosmos.com

]]>
APAC IUCD Devices Market Thu, 11 Jan 2018 17:38:34 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465587.html http://comunicati.net/comunicati/aziende/tecnologia/465587.html Market Data Forecast Market Data Forecast In this region, The APAC IUCD Devices Market is projected to reach USD 2,533.9 million by 2024, from USD 2,161.5 million in 2016 growing at a CAGR of 2.0% in the forecast period 2017 to 2024.

 

Based on geography, the APAC IUCD devices market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-iucd-devices-market-analysis-industry-outlook-and-forecast-2017-to-2024/1571292475

 

APAC IUCD devices market competition by top players including –

Bayer AG dominated the IUCD devices market, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Also Medigen Distribution, Inc. and Allergen PLC are expected to hold respectively. Some of the other players in this market include

DKT International,

Egemen International,

Melbea AG,

Ocon Medical Ltd.,

Pregna International Limited,

Medical Engineering Corporation SA

SMB Corporation

Meril Life Sciences Pvt. Ltd.,

Medu Scientific Ltd,

China RH Contraceptives Co., Ltd,

Sanghai Jolly Medical Education Co., Ltd,

Bernstein Leibhard LLP,

ZheijangDaji Medical Instruments, Ltd.,

Nimble International,

AME Line,

Technico,

Cepeo,

Contraceptivos,

InjeflexIndand Com Ltda,

Bersil, Amed

 

Request free sample @ https://www.researchcosmos.com/request/1571292475

 

The APAC intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

 

The APAC intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1571292475

 

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare.

 

Check for discount @https://www.researchcosmos.com/discount/1571292475

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
APAC Hemostats Market Thu, 11 Jan 2018 17:38:12 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465586.html http://comunicati.net/comunicati/aziende/tecnologia/465586.html Market Data Forecast Market Data Forecast In this report, APAC Hemostats Market is expected to reach USD 595.1 million by 2024, from USD 327.6 million in 2016 growing at a CAGR of 7.8% in the forecast period 2017 to 2024.

 

Based on geography, the APAC hemostats market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-hemostats-market-analysis-industry-outlook-and-forecast-2017-to-2024/1938253804

 

APAC hemostats market competition by top players including -

Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as

Baxter,

Vascular Solutions, Inc.,

B.Braun Melsungen,

3-D Matrix, Ltd.,

Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company),

Anika Therapeutics, Inc.,

Arch Therapeutics Inc.,

Biom’Up SAS,

CryoLife, Inc.,

Gamma Therapeutics, Inc.,

Hemostasis, LLC,

MedTrade Products Limited, I

ntegra LifeSciences Corporation,

Medline Industries, Inc.,

HEMOTEC MEDICAL GMBH,

Stryker,

CSL Behring,

Mallinckrodt,

Equimedical, B.V.

 

Request free sample @ https://www.researchcosmos.com/request/1938253804

 

The APAC hemostats market is segmented on the basis of type, application, distribution channel, and end user.

 

 

The APAC hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/1938253804

 

On the basis of application, the market is segmented into surgery and wound closure.

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics.

 

Check for discount @https://www.researchcosmos.com/discount/1938253804

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
APAC Body Composition Analyzers Market Thu, 11 Jan 2018 17:37:45 +0100 http://comunicati.net/comunicati/aziende/tecnologia/465585.html http://comunicati.net/comunicati/aziende/tecnologia/465585.html Market Data Forecast Market Data Forecast In this report, The APAC Body Composition Analyzers Market is projected to reach USD 218.26 million by 2024 from USD 114.81 million in 2016, growing at the highest CAGR of 8.5%.

 

Based on geography, the APAC body composition analyzers market is segmented into 11 geographical regions, such as,

Japan,

China,

South Korea,

India,

Australia,

Singapore,

Thailand,

Malaysia,

Indonesia,

Philippines and

Rest of APAC.

 

Explore More Information about report @ https://www.researchcosmos.com/reports/apac-body-composition-analysers-market-analysis-industry-outlook-and-forecast-2017-to-2024/146391424

 

APAC body composition analyzers market competition by top players including -

Tanita

InBody CO., LTD.

Omron Healthcare, Inc.

Selvashealthcare

Bodystat

Hologic, Inc.

GE Healthcare

COSMED

Beurer GmbH

seca

RJL SYSTEMS

Maltron International Ltd.

Laica SpA

 

Request free sample @ https://www.researchcosmos.com/request/146391424

 

The APAC body composition analyzers market is segmented on the basis of product type, end-users and region.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/146391424

The 5 types of products are Bio impedance Analyzers (BIA), Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography (ADP), and others (Hydrostatic Weighing (HwD), Ultrasound Body Composition).

 

The major end-users of the market are Health Clubs, Hospitals and Clinics, Corporate Settings, and others (Medical Research, Universities).

 

Check for discount @https://www.researchcosmos.com/discount/146391424

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line:+1 888 709 8757

Mail:dani@researchcosmos.com

www.researchcosmos.com

 

 

]]>
Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size Thu, 07 Dec 2017 14:36:21 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461842.html http://comunicati.net/comunicati/aziende/tecnologia/461842.html Market Data Forecast Market Data Forecast Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 2.215% CAGR from 2016 to 2021 and it is estimated that the Middle East and Africa market was valued at USD 24.72 million in 2016 and is expected to reach USD 27.58 million by 2021.

 

ECMO stands for extracorporeal membrane oxygenation. The ECMO machine is similar to the heart-lung by-pass machine used in open-heart surgery. It pumps and oxygenates a patient's blood outside the body, allowing the heart and lungs to rest. When you are connected to an ECMO, blood flows through tubing to an artificial lung in the machine that adds oxygen and takes out carbon dioxide; then the blood is warmed to body temperature and pumped back into your body. There are two types of ECMO. The VA ECMO is connected to both a vein and an artery and is used when there are problems with both the heart and lungs. The VV ECMO is connected to one or more veins, usually near the heart, and is used when the problem is only in the lungs. USCF is also now using a smaller portable ECMO device that is light enough to be carried by one person and can be transported in an ambulance or helicopter, making it possible to provide ECMO relief in emergency cases.

 

Full report at: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-extracorporeal-membrane-oxygenation-machine-market-4982/

 

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

 

Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Segmentation by Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.

 

Request sample: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-extracorporeal-membrane-oxygenation-machine-market-4982/request-sample

 

On the basis of geography, the market is analyzed under various regions namely Middle East and Africa. The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. Manufacturing medical devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality.

 

Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>
Latin America Extracorporeal Membrane Oxygenation Machine Market Size Thu, 07 Dec 2017 14:11:12 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461833.html http://comunicati.net/comunicati/aziende/tecnologia/461833.html Market Data Forecast Market Data Forecast Latin America Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 4.54% CAGR from 2016 to 2021 and it is estimated that the Latin-America market was valued at USD 29.66 million in 2016 and is expected to reach USD 37.04 million by 2021.ECMO stands for extracorporeal membrane oxygenation. The ECMO machine is similar to the heart-lung by-pass machine used in open-heart surgery. It pumps and oxygenates a patient's blood outside the body, allowing the heart and lungs to rest. When you are connected to an ECMO, blood flows through tubing to an artificial lung in the machine that adds oxygen and takes out carbon dioxide; then the blood is warmed to body temperature and pumped back into your body. There are two types of ECMO. The VA ECMO is connected to both a vein and an artery and is used when there are problems with both the heart and lungs. The VV ECMO is connected to one or more veins, usually near the heart, and is used when the problem is only in the lungs. USCF is also now using a smaller portable ECMO device that is light enough to be carried by one person and can be transported in an ambulance or helicopter, making it possible to provide ECMO relief in emergency cases.

 

Full report at: http://www.marketdataforecast.com/market-reports/latin-america-extracorporeal-membrane-oxygenation-machine-market-4981/

 

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

 

The Latin America Extracorporeal Membrane Oxygenation Machine Market Segmentation by Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.

 

Request sample: http://www.marketdataforecast.com/market-reports/latin-america-extracorporeal-membrane-oxygenation-machine-market-4981/request-sample

 

On the basis of geography, the market is analyzed under various regions namely Argentina, Brazil and Mexico. The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. Manufacturing medical devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality.

 

Latin America Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>
Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size, and Share Wed, 06 Dec 2017 12:52:56 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461701.html http://comunicati.net/comunicati/aziende/tecnologia/461701.html Market Data Forecast Market Data Forecast Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 5.45% CAGR from 2016 to 2021 and it is estimated that the Asia-Pacific market was valued at USD 44.5 million in 2016 and is expected to reach USD 58.02 million by 2021.The term extracorporeal membrane oxygenation (ECMO) was initially used to describe long-term extracorporeal support that focused on the function of oxygenation. Subsequently, in some patients, the emphasis shifted to carbon dioxide removal, and the term extracorporeal carbon dioxide removal was coined. Extracorporeal support was later used for postoperative support in patients following cardiac surgery. Other variations of its capabilities have been tested and used over the last few years, making it an important tool in the armamentarium of life and organ support measures for clinicians. With all of these uses for extracorporeal circuitry, a new term, extracorporeal life support (ECLS), has come into vogue to describe this technology.

 

Full report at: http://www.marketdataforecast.com/market-reports/asia-pacific-extracorporeal-membrane-oxygenation-machine-market-4980/

 

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population in countries like India and China, and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

 

The Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Segmentation by Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.

 

Request sample: http://www.marketdataforecast.com/market-reports/asia-pacific-extracorporeal-membrane-oxygenation-machine-market-4980/request-sample

 

On the basis of geography, the market is analyzed under various regions namely India, China, Japan, South America and Australia. The Asia-Pacific market is expected to grow at the highest CAGR and aid the revenue pocket for companies offering ECMO systems.  Factors such as favorable reimbursement scenario in Japan, rising cardiovascular diseases in China, growing application and adoption of extracorporeal membrane oxygenation machine in India, and rising cardiopulmonary disorders in Australia are driving the growth of the market in this region.

 

Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>
Europe Extracorporeal Membrane Oxygenation Machine Market Size, Share, and Trends Wed, 06 Dec 2017 12:27:40 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461696.html http://comunicati.net/comunicati/aziende/tecnologia/461696.html Market Data Forecast Market Data Forecast Europe Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 4.39% CAGR from 2016 to 2021 and it is estimated that the Europe market was valued at USD 61.8 million in 2016 and is expected to reach USD 76.61 million by 2021.

 

Extracorporeal membrane oxygenation, or ECMO, is a treatment used for patients with life-threatening heart and/or lung problems. It provides long-term breathing and heart support and is used only when all of the standard treatments for those problems have already been tried. ECMO can support patients for days to weeks while doctors treat their underlying illness. ECMO is performed using a heart-lung bypass machine similar to the one used during open heart surgery. The ECMO machine, often referred to as a “circuit,” is quite large and contains sterile plastic tubing that moves blood from your baby to the “ECMO lung” and then back to your child. The ECMO lung adds oxygen to the blood and removes carbon dioxide, as a healthy lung would.

 

Full report at: http://www.marketdataforecast.com/market-reports/europe-extracorporeal-membrane-oxygenation-machine-market-4979/

 

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

 

The Europe Extracorporeal Membrane Oxygenation Machine Market segmentation by Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.

 

 Request sample: http://www.marketdataforecast.com/market-reports/europe-extracorporeal-membrane-oxygenation-machine-market-4979/request-sample

 

On the basis of geography, the market is analyzed under various regions namely Germany, France, U.K., Italy and Spain. Europe accounts for the second largest share of the market. The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers are expected to boost the market.

 

Europe Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>
North America Extracorporeal Membrane Oxygenation Machine Market Size, Share, and Trends Tue, 05 Dec 2017 14:08:08 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461589.html http://comunicati.net/comunicati/aziende/tecnologia/461589.html Market Data Forecast Market Data Forecast North America Extracorporeal Membrane Oxygenation Machine Market Size is expected to grow at a 4.12% CAGR from 2016 to 2021 and it is projected that the North-America market was valued at USD 86.52 million in 2016 and is anticipated to reach USD 105.87 million by 2021.

 

ECMO stands for extracorporeal membrane oxygenation. The ECMO machine is similar to the heart-lung by-pass machine used in open-heart surgery. It pumps and oxygenates a patient's blood outside the body, allowing the heart and lungs to rest. When you are connected to an ECMO, blood flows through tubing to an artificial lung in the machine that adds oxygen and takes out carbon dioxide; then the blood is warmed to body temperature and pumped back into your body. There are two types of ECMO. The VA ECMO is connected to both a vein and an artery and is used when there are problems with both the heart and lungs. The VV ECMO is connected to one or more veins, usually near the heart, and is used when the problem is only in the lungs. USCF is also now using a smaller portable ECMO device that is light enough to be carried by one person and can be transported in an ambulance or helicopter, making it possible to provide ECMO relief in emergency cases.

 

Full report at: http://www.marketdataforecast.com/market-reports/north-america-extracorporeal-membrane-oxygenation-machine-market-4978/

 

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

 

The North America Extracorporeal Membrane Oxygenation Machine Market Segmentation on the basis of Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.

 

http://www.marketdataforecast.com/market-reports/north-america-extracorporeal-membrane-oxygenation-machine-market-4978/request-sample

 

On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North America held the largest share of the market.  The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S. is expected to boost the market for ECMO systems in North America.

 

Some of the Major North America Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>
Middle East and Africa Cardiac Marker Testing Market Size, Share, and Trends Tue, 05 Dec 2017 12:21:12 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461579.html http://comunicati.net/comunicati/aziende/tecnologia/461579.html Market Data Forecast Market Data Forecast Middle East and Africa Cardiac Marker Testing Market Size is anticipated to grow at 5.269% CAGR from 2016 to 2021 and it is estimated that the Middle East and Africa market was valued at USD 0.18 billion in 2016 and is expected to reach USD 0.24 billion by 2021.

 

Cardiac markers are biomarkers used to measure and the evaluate heart function. They are primarily discussed in reference of myocardial infarction, but other conditions can lead to an elevation in cardiac marker level. Most of the early markers identified were enzymes, and as an effect of that, the term "cardiac enzymes" is used every now and then. Be that as it may, not all of the markers are presently used are enzymes.

 

Full report at: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-cardiac-marker-testing-market-4988/

 

Factor such as increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth.  Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.

 

The Middle East and Africa Cardiac Marker Testing Market Segmentation by Type, Product, Disease, and Testing. On the basis of Type, it is segmented into Troponin I & T, CK-MB, Myoglobin, BNP, and hsCRP. The creatine kinase segment is further segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of this market segment. On the basis of Product, it is segmented into Reagent and Instrument. The instrument segment is furtherer segmented into Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA. On the basis of Disease, it is segmented into Acute Coronary Syndrome, Myocardial Infarction, and Congestive Heart Failure. ACS is expected to be the fasting growing segment driven. Myocardial infarction is anticipated to be the second fastest growing segment. On the basis of Testing, it is segmented into Lab and POC. The laboratory testing segment is expected to hold the largest share of this market segment, while the point-of-care testing segment is expected to register the highest growth rate in this market segment.

 

On the basis of geography, the market is analyzed under various regions namely Middle East and Africa. The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. Manufacturing these devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality.

 

Request sample: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-cardiac-marker-testing-market-4988/request-sample

 

The market is dominated by companies like the Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>
Latin America Cardiac Marker Testing Market Size, Share, Trends and Overview 2021 Mon, 04 Dec 2017 14:01:50 +0100 http://comunicati.net/comunicati/aziende/tecnologia/461478.html http://comunicati.net/comunicati/aziende/tecnologia/461478.html Market Data Forecast Market Data Forecast Latin America Cardiac Marker Testing Market is anticipated to grow at 9.45% CAGR from 2016 to 2021 and it is estimated that the Latin-America market was valued at USD 0.28 billion in 2016 and is expected to reach USD 0.44 billion by 2021.

 

Cardiac markers are biomarkers used to measure and the evaluate heart function. They are primarily discussed in reference of myocardial infarction, but other conditions can lead to an elevation in cardiac marker level. Most of the early markers identified were enzymes, and as an effect of that, the term "cardiac enzymes" is used every now and then. Be that as it may, not all of the markers are presently used are enzymes.

 

Full report at: http://www.marketdataforecast.com/market-reports/latin-america-cardiac-marker-testing-market-4987/

 

Factor such as increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth.  Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.

 

The Latin America Cardiac Marker Testing Market Segmentation by Type, Product, Disease, and Testing. On the basis of Type, it is segmented into Troponin I & T, CK-MB, Myoglobin, BNP, and hsCRP. The creatine kinase segment is further segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of this market segment. On the basis of Product, it is segmented into Reagent and Instrument. The instrument segment is furtherer segmented into Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA. On the basis of Disease, it is segmented into Acute Coronary Syndrome, Myocardial Infarction, and Congestive Heart Failure. ACS is expected to be the fasting growing segment driven. Myocardial infarction is anticipated to be the second fastest growing segment. On the basis of Testing, it is segmented into Lab and POC. The laboratory testing segment is expected to hold the largest share of this market segment, while the point-of-care testing segment is expected to register the highest growth rate in this market segment.

 

On the basis of geography, the market is analyzed under various regions namely Argentina, Brazil and Mexico. The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. Manufacturing these devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality.

 

Request sample: http://www.marketdataforecast.com/market-reports/latin-america-cardiac-marker-testing-market-4987/request-sample

 

The market is dominated by companies like the Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

]]>